Overview

Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
0
Participant gender:
All
Summary
Smokers report that they often smoke cigarettes during stressful times. The combined effect of smoking and exposure to stress leads to exaggerated increases in blood pressure, heart rate and other measures of stress response. This combination may result in greater cardiovascular harm than either smoking or stress alone. The purpose of this study is to determine the effects of paroxetine on the response to stress after smoking.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Paroxetine
Criteria
Inclusion Criteria:

- Smokes an average of at least 10 cigarettes per day during the year prior to
enrollment

Exclusion Criteria:

- Interested in quitting smoking within the 3 months following enrollment

- Current unstable medical condition

- Substance abuse within the year prior to enrollment

- Current use of any medications (e.g., psychoactive medications, antihypertensives)
that, in the opinion of the investigators, might interfere with study measures or that
would be expected to interact with paroxetine (e.g., CYP2D6 substrates)

- Smoking cessation therapy within the 3 months prior to enrollment

- Regular use of any form of tobacco other than cigarettes

- Significant psychiatric disorders as assessed by the PRIME-MD and verified by a
clinician

- History of hypersensitivity to any selective serotonin reuptake inhibitor

- Pregnancy or breastfeeding